Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
23.27
+0.16 (0.69%)
At close: May 6, 2026, 4:00 PM EDT
23.02
-0.25 (-1.07%)
After-hours: May 6, 2026, 7:38 PM EDT
Immunome Employees
Immunome had 177 employees as of December 31, 2025. The number of employees increased by 59 or 50.00% compared to the previous year.
Employees
177
Change (1Y)
59
Growth (1Y)
50.00%
Revenue / Employee
$39,215
Profits / Employee
-$1,199,966
Market Cap
2.64B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 177 | 59 | 50.00% |
| Dec 31, 2024 | 118 | 63 | 114.55% |
| Dec 31, 2023 | 55 | 18 | 48.65% |
| Dec 31, 2022 | 37 | -2 | -5.13% |
| Dec 31, 2021 | 39 | 16 | 69.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Tarsus Pharmaceuticals | 370 |
| Vera Therapeutics | 249 |
| Celldex Therapeutics | 198 |
| Relay Therapeutics | 192 |
| Soleno Therapeutics | 182 |
| Disc Medicine | 155 |
| IDEAYA Biosciences | 145 |
IMNM News
- 1 day ago - Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 days ago - Immunome Announces Submission of New Drug Application to U.S. FDA for Varegacestat for the Treatment of Adults with Desmoid Tumors - Business Wire
- 15 days ago - Immunome Announces Oral Presentation of Phase 3 RINGSIDE Data at 2026 ASCO Annual Meeting - Business Wire
- 22 days ago - Immunome (IMNM) Price Forecast: Breakout Points to Higher Highs Ahead - FXEmpire
- 2 months ago - Immunome Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Immunome Reports Full Year 2025 Financial Results and Provides Business Update - Business Wire
- 2 months ago - Immunome Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Immunome to Present at Upcoming Investor Conferences - Business Wire